SEOUL, Aug. 21 (Korea Bizwire) — SK bioscience Co., the biotech arm of South Korea’s SK Group, said Thursday it will expand cooperation with the Gates Foundation on next-generation preventive medicines, with a focus on research and development (R&D) for pandemic preparedness. Officials from SK bioscience and the foundation held a meeting in Seoul on [...]
SEOUL, May 21 (Korea Bizwire) — SK bioscience Co., a biotech arm of South Korea’s SK Group, said Wednesday it has won a patent lawsuit against global pharmaceutical giant Pfizer Inc. over pneumococcal vaccine components. In 2020, Pfizer filed a lawsuit with a Korean court, claiming that SK bioscience’s export of 13-valent pneumococcal conjugate vaccine [...]
SEOUL, April 23 (Korea Bizwire) – SK bioscience Co., the biopharmaceutical arm of South Korea’s SK Group, said Wednesday it has achieved a “final victory” in a patent invalidation case against Moderna, the global developer of the messenger-RNA (mRNA) COVID-19 vaccine. SK bioscience filed a nullity suit in 2023 challenging Moderna’s patent on modified nucleosides, [...]
SEOUL, Dec. 4 (Korea Bizwire) – SK Bioscience has prevailed in an appellate court ruling against Pfizer’s subsidiary, Wyeth LLC, in a patent infringement lawsuit concerning the export of pneumococcal vaccine components to Russia. The Patent Court of Korea overturned a lower court decision, ruling that SK Bioscience’s supply of the 13-valent pneumococcal conjugate vaccine [...]
SEOUL, Oct. 2 (Korea Bizwire) — SK bioscience Co., a biopharmaceutical arm of South Korea’s SK Group, said Wednesday it has completed its acquisition of a controlling stake in the German biotech company IDT Biologika. In June, the Korean company agreed to take over a 60 percent stake in IDT Biologika from Klocke Group for [...]
SEOUL, Jul. 25 (Korea Bizwire) — SK bioscience Co., a biopharmaceutical arm of South Korea’s SK Group, said Thursday it has agreed to invest US$2 million to acquire future shares in U.S. biotech company Sunflower Therapeutics. SK bioscience signed a simple agreement for future equity (SAFE) with Sunflower Therapeutics as part of efforts to expand [...]
SEOUL, Jun. 27 (Korea Bizwire) — SK bioscience Co., a biopharmaceutical arm of South Korea’s SK Group, said Thursday it has agreed to pay 339 billion won (US$243 million) for control of German biotech company IDT Biologika. The acquisition of IDT Biologika will give SK bioscience a crucial gateway for its expansion plans in the [...]
SEOUL, Dec. 12 (Korea Bizwire) — SK bioscience Co. said Tuesday it has started supplying Novavax’s updated COVID-19 vaccine to target the XBB.1.5 subvariant in South Korea. The vaccine, the only non-messenger RNA formulation against COVID-19 in the world, will be available for free at designated hospitals and health centers across the country starting next [...]
SEOUL, Aug. 24 (Korea Bizwire) — SK bioscience Co. said Thursday it has reached a deal with Vaxxas, an Australian biotechnology company, to jointly develop a new patch-type typhoid vaccine. The global charitable foundation Wellcome will fund the collaboration for the first two years, awarding US$3.67 million to conduct the first-phase clinical trial, according to [...]
SEOUL, Aug. 23 (Korea Bizwire) — SK bioscience Co., a pharmaceutical affiliate under South Korea’s SK Group, said Wednesday it will produce 5 million doses of its signature cell-based influenza vaccine SKYCellflu nationwide from next month for the coming winter season. It resumed the production two years after it had stopped manufacturing the prefilled syringe-typed [...]